期刊文献+

食管癌切除术后不同重建途径随机对照试验Meta分析 被引量:4

Meta-analysis of randomised controlled trials for route of reconstruction after esophagectomy for cancer
原文传递
导出
摘要 目的:评估食管癌切除术后食管胃经胸骨后或食管床2种重建途径吻合对患者术后的影响。方法:计算机检索Coeharane Library、PubMed、EMBASE、中国生物医学文献数据库、中国期刊全文数据库和中文科技期刊全文数据库,检索时间从各数据库建库至2012-12;同时辅助其他检索,纳入食管癌切除术后食管胃经胸骨后或食管床2种重建途径吻合的随机对照试验(randomized controlled trial,RCT)。由2名评价者独立评价纳入研究的质量并提取资料,用Rev—Man5.0软件进行统计分析。结果:共纳入11篇RCT,中文3篇,英文8篇,共998例患者。Meta分析结果显示,与胸骨后重建途径比较,食管床途径能明显减少食管胃吻合口瘘发生率(OR一0.52,95%CI:0.33~0.82,P=0.005)和吻合口狭窄的发生率(OR=0.40,95%CI:0.25~0.66,P〈0.001),心、肺并发症和住院死亡率差异无统计学意义,其0R值(95%CI)分别为0.50(0.24~1.04)、0.98(0.58~1.65)和0.97(0.27~3.39),P值分别为0.06、0.93和0.96。结论:食管癌切除术后食管胃经食管床途径较胸骨后途径能明显减少吻合口瘘和吻合口狭窄的发生率,使患者受益。 OBJECTIVE:To evaluate the effects of different routes of reconstruction on patient outcomes after esophagectomy for cancer. METHODS:CBM, VIP, CNKI,Coehrane Library, Pubmed and Embase etc were searched by computer since the establishment of these datebases to December 2012. We also traced related references and experts in this field and communicated with other authors to obtain certain informations that had not been found. Randomized and quasi-randomized controlled trials compared route of gastric conduit reconstruction after esophageetomy for cancer were included. The statistical software RevMan 5.0 was used. RESULTS:Totally 11 published articals were selected (998 patients) including Chinese articls and English articles. The results of Meta-analysis showed that compared with retrosternal route,posterior mediastinal route reduced the rates of anastomotic leaks and anastomotic strictures, (OR = 0. 52,95 % CI:0.33- 0.82, P = 0.005 ;OR= 0.40,95% CI: 0.25 - 0.66, P〈0.001). There was not any difference in operative mortality, cardiac complications and pulmonary complications for the two routes of reconstruction(OR= 0.50,95 % CI : 0.24 - 1.04, P = 0.06 ; OR = 0.98,95% CI:0.58-1.65,P=0.93;OR=0.97,95%CI:0.27-3.39,P=0.96). CONCLUSION:compared with retrosternal route,posterior route of reconstruction reduces the rates of anastomotic leaks and anastomotic strictures.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2014年第9期705-710,共6页 Chinese Journal of Cancer Prevention and Treatment
关键词 食管肿瘤 外科学 重建途径 系统评价 随机对照试验 META分析 esophageal neoplasms/surgery reconstructive surgical procedures systematic review randomized controlled trial Meta-analysis
  • 相关文献

参考文献17

  • 1Urschel JD,Urschel DM, Miller JD,et al. A meta-analysis of random-ized controlled trials of route of reconstruction after esophagectomy forcancer[J]. Am J Surg,2001,182(5) :470-475.
  • 2Bartels H,Thorban S,Siewert J. Anterior versus posterior recon-struction after transhiatal oesophagectomy : a randomized con-trolled trial[J]. Br J Surg,1993,80(9) : 1141-1144.
  • 3傅俊惠,黄建豪,吴智勇,等.食管癌切除管状胄替代重建(386例报告)[G]//第四届全国肿瘤学进展学术会议论文集,杭州:杭州出版社,2007:187-191.
  • 4Gawad K, Hosch S, Bumann D, et al. How important is the route ofreconstruction after esophagectomy: a prospective randomized study[J], Am J Gastroenterol,1999,94(6) :1490-1496.
  • 5Khiria L,Pal S.Peush S,et al. Impact on outcome of the route of con-duit transposition after transhiatal oesophagectomy . A randomized con-trolled triaO]- Dig Liver Ds,2009,41(10) :711-716.
  • 6马骏.管状胃成形胃代食管吻合术在食管癌手术中的应用[J].中菌实用医刊,2012,39(7) :106-107.
  • 7Singla N,Kaman L,Singh R. Anterior route reconstruction after tran-shiatal esophagectomy is comparable with posterior route reconstruction[J], Indian J Gastroenterol,2007,26(3) : 143-145.
  • 8Van Lanschot J, Van Blankenstein M,Oei H,et al. Randomizedcomparison of prevertebral and retrosternal gastric tube recon-struction after resection of oesophageal carcinoma[J], Br J Surg,1999,86(1)..102-108.
  • 9张志锋,洪祎纯,韦武芝,吴伟斌,曾贵青,蔡伟明,吕文强.食管癌三切口手术中管状胃两种不同上提径路的临床观察[J].中华全科医学,2012,10(6):875-876. 被引量:10
  • 10Zieren H,Muller M,Pichlmaier H. Prospective randomized studyof one-or two-layer anastomosis following oesophageal resectionand cervical oesophagogastrostomy[J]. Br J Surg, 1993,80(5):608-611.

二级参考文献11

共引文献23

同被引文献37

  • 1朱天翔,蓝斌,李锐雄,方忠民,王沐廷,杨彦龙.食管胃颈部吻合术中管状胃经胸骨后与食管床不同上提路径的比较[J].食管外科电子杂志,2013(4):145-149. 被引量:3
  • 2Liu L, Wang J, Li X, et al. miR-204-5p suppresses cell prolifer- ation by inhibiting IGFBP5 in papillary thyroid carcinoma[J]. Biochem Biophys Res Commun, 2015, 457(4):621-626.
  • 3Ma L, Deng X, Wu M, et al. Down-regulation of miRNA-204 by LMP-1 enhances CDC42 activity and facilitates invasion of EBV associated nasopharyngeal carcinoma cells[J]. FEBS Lett, 2014, 588(9) :1562-1570.
  • 4Ryan J, Tivnan A, Fay J, et al. MicroRNA-204 increases sensi- tivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcom[J ]. Br J Cancer, 2012,107 (6) : 967-976.
  • 5Zeng L, Yu J, Huang T, et al. Differential combinatorial regu- latory network analysis related to venous metastasis of hepato- cellular carcinoma[J/OL]. BMC Genomics, 2012, 13 ( Suppl 8) : $14.
  • 6Zeng H, Zheng R, Guo Y, et al. Cancer survival in? China, 2003-2005: A population-based study[J]. Int J Cancer, 2014. [-Epuh ahead of print].
  • 7Chen Z, Sangwan V, Banerjee S, et al. miR-204 mediated loss of Myeloid cell leukemia-1 results in pancreatic cancer cell death [J]. Mol Cancer, 2013,12(1) : 105.
  • 8Qiu YH,Wei YP,Shen NJ, et ai. miR-204 inhibits epithelial to messenchymal tromsition by targeting slug in intrahepatic cholomgio carcinoma cells[J]. Cell Phgsiol Biochem, 2013,32 (5) :1331-1341.
  • 9Shi L, Zhang B, Sun X, et al. MiR-204 inhibits human NSCLC metastasis through suppression o{ NUAK1 [J]. Br J Cancer, 2014, 111(12) :2316-2327.
  • 10Hall DP, Cost NG, Hegde S, et al. TRPM3 and miR-204 estab- lish a regulatory circuit that controls oncogenie autophagy in clear cell renal cell carcinoma[J]. Cancer Cell, 2014, 26 (5) : 738-753.

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部